skip to navigation

Resources

Featured Resources

ICO Strategic Plan 2017–2020

The ICO has defined a strategic plan covering 2017-2020. You can download a summary of the ICO Strategic Plan (PDF -… More »

PDF

ICO Exams Instructions for Candidates and Syllabus: Advanced

Instructions for Candidates and Syllabus for Advanced Exam. More »

URL

Cybersight from Orbis

Cybersight® is a telehealth and education program focused on increasing the capacity of human resources in eye health… More »

Topic Subspecialty Rating Date ICO Member Resource Name & Description Author

Advocacy/Vision 2020

Diabetic Eye Care

not yet rated March 16, 2017 Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement. These improvements include the widespread adoption of optical coherence tomography to assess retinal thickness and intraretinal pathology and wide-field fundus photography to reveal clinically silent microvascular lesions. Treatment of diabetic macular edema is now achieved by intravitreous injection of anti–vascular endothelial growth factor agents, and the same drugs are now used for proliferative diabetic retinopathy. Improvements in medications and devices for the systemic therapy of diabetes have also improved the ability of patients to optimize their metabolic control. This Position Statement incorporates these recent developments for the use of physicians and patients.


URL | Save to My ICO
American Diabetes Association

Stay connected:         Follow us on Instagram

Web site design and web development by D3 Solutions